Lifecore Biomedical (LCBM) Acquried By Warburg Pincus for $17/Share
Lifecore Biomedical (Nasdaq: LCBM) entered into a definitive agreement with affiliates of Warburg Pincus, the global private equity firm, to be acquired through a tender offer, followed by a merger, for a price of $17.00 per share in cash.
Lifecore Biomedical closed at $12.84 per share on Monday.
Lifecore Biomedical expects the transaction to close by the end of the first quarter of 2008.
Lifecore Biomedical closed at $12.84 per share on Monday.
Lifecore Biomedical expects the transaction to close by the end of the first quarter of 2008.
You May Also Be Interested In
- UPDATE: Angelo, Gordon to Acquire Benihana (BNHN) for $16.30/Share in Cash
- Dollar Thrifty (DTG) Shares Spike Higher as Hertz (HTZ) Could Make an Offer
- Amylin (AMLN) Shares Jump as Bids Due Today, Sanofi (SNY), Merck (MRK) Said to Make First-Round Bids
Create E-mail Alert Related Categories
Hot List, Mergers and AcquisitionsRelated Entities
Warburg PincusSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
